Skip to main content

Table 3 Comparison of treatments and outcomes between survivors and non-survivors

From: Clinical outcomes of extracorporeal membrane oxygenation in acute traumatic lung injury: a retrospective study

 TotalSurvivorsNon-survivorsP
n = 42 (%)n = 34 (81%)n = 8 (19%)
ECMO types   0.001*
 VV29 (69)28 (66.7)1 (2.4) 
 Other types13 (31)6 (14.3)7 (16.7) 
Anticoagulation   0.655
 Heparin11 (26.2)9 (21.4)2 (4.8) 
 Nafamostat mesilate31 (73.8)25 (59.5)6 (14.3) 
ECMO time (hours), median (IQR)155 (90.5–232.5)160 (114.0–240.7)24 (4.0–132.0)0.021*
CRRT24 (57.1)19 (45.2)5 (11.9)0.527
Transfusion (U/day) during ECMO period, median (IQR)
 Packed RBC1 (0.5–2.6)0.7 (0.4–1.7)5.7 (1.6–59.2)0.001*
 Fresh frozen plasma0.2 (0–1.3)0.2 (0–0.7)4.7 (0.9–29.3)0.001*
 Platelet concentrate0.1 (0–2.3)0 (0–1.4)7 (0–11.5)0.001*
 Cryoprecipitate0.0 (0–0)0.0 (0–0)0 (0–2.9)0.09
ICU stay (days), median (IQR)16 (7.7–24.2)17.5 (9.7–25.7)3 (1.0–8.5)0.014*
Hospital stay (days), median (IQR)23 (13.2–51.2)28 (18–58.5)3 (1.0–8.5)0.006*
  1. Abbreviations: CRRT continuous renal replacement therapy, ECMO extracorporeal membrane oxygenation, ICU intensive care unit, IQR interquartile range, RBC red blood cells, VV veno-venous
  2. *Statistically significant, P < 0.05